Date: August 27, 2019 Source: Forschungsverbund Berlin Summary:A team led by the scientist has now discovered how inactivation of a certain lipid kinase promotes mTor complex 1 activity, and may therefore constitute a new point of attack for the treatment of diabetes and cancer. The activation of mTor complex 1 in the cell is central to many vital processes...